secwatch / observer
8-K filed February 20, 2024, 6:59 PM ET ticker AIM CIK 0000946644
debt confidence high sentiment neutral materiality 0.50

AIM ImmunoTech Inc. (AIM): debt financing — AIM ImmunoTech raises $2.5M via private placement of 10% unsecured promissory note

AIM ImmunoTech Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

AIM ImmunoTech Inc. incurred loan of $3,301,250 with Streeterville Capital, LLC at ten percent (10%) per annum compounded daily maturing 24 months from the date of its issuance.

Instrument
loan
Principal
$3,301,250
Counterparty
Streeterville Capital, LLC
Rate
ten percent (10%) per annum compounded daily
Maturity
24 months from the date of its issuance
Event
incurrence
Exact text from the filing
On February 16, 2024, AIM ImmunoTech Inc. (the “Company”, “we”, “us” or “our”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with Streeterville Capital, LLC (the “Investor”) and consummated the sale to such Investor of an unsecured Promissory Note (the “Note”) with an original principal amount of $3,301,250 in a private placement (the “Private Placement”) that closed on February 16, 2024. The Note carries an original issuance discount of $781,250 and the Company agreed to pay $20,000 to the Investor to cover the Investor’s legal and administrative transaction costs, each of which were included in the original principal amount and deducted from the proceeds of the Note received by the Company which resulted in a purchase price received by the Company of $2,500,000. The Note bears interest at ten percent (10%) per annum compounded daily. The maturity date of the Note is 24 months from the date of its issuance (the “Maturity Date”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AIM ImmunoTech Inc. entered into Note Purchase Agreement with Streeterville Capital, LLC valued at $3,301,250 original principal amount (effective 2024-02-16).

Action
entry
Agreement
notes offering
Counterparty
Streeterville Capital, LLC
Value
$3,301,250 original principal amount
Effective
2024-02-16
Exact text from the filing
On February 16, 2024, AIM ImmunoTech Inc. (the “Company”, “we”, “us” or “our”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with Streeterville Capital, LLC (the “Investor”) and consummated the sale to such Investor of an unsecured Promissory Note (the “Note”) with an original principal amount of $3,301,250 in a private placement (the “Private Placement”) that closed on February 16, 2024.
View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

AIM ImmunoTech Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-007230
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.